United Therapeutics Corp

NASDAQ:UTHR

294.49

-0.73 (-0.25%)

4:32:30 PM EDT: $294.49 0.00 (0.00%)

Market Cap (Intraday)	13.25B
Current PE	10.94
Forward PE	10.56
2yr Forward PE	10.03

See more stats

Estimates Current Quarter

Revenue	$804.98 Million
Adjusted EPS	$7.35

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

United Therapeutics Corp Stock, NASDAQ:UTHR

1000 Spring Street, Silver Spring, Maryland 20910

United States of America

Phone: +1.301.608.9292

Number of Employees: 1305

http://www.unither.com

Description

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.